SCHEMBL19851719

SCHEMBL19851719

CCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)COCCCCCCCCCCCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.51
CTSS P25774 2/20 0.51
TLR2 O60603 6/20 0.49
SIRT6 Q8N6T7 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CXCR3 P49682 1/20 0.42
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
CAPN1 P07384 1/20 0.41
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19851698 0.90 TLR2 (0.63) CTSKCTSSTLR2
SCHEMBL19851522 0.85 TLR2 (0.70) TLR2SIRT6SIRT1CA1CA2
SCHEMBL19851525 0.85 TLR2 (0.70) TLR2SIRT6SIRT1CA1CA2
SCHEMBL20542796 0.81 CTSK (0.70) CTSKCTSSSIRT6SIRT1CA1
SCHEMBL20542797 0.81 CTSK (0.70) CTSKCTSSSIRT6SIRT1CA1
SCHEMBL12179560 0.81 TDP1 (0.58) CTSKCTSSCA1CA2CXCR3
SCHEMBL16572097 0.79 CTSK (0.60) CTSKCTSSSIRT6SIRT1CA1
SCHEMBL19543629 0.79 CTSS (0.53) CTSKCTSSCA1CA2CXCR3
SCHEMBL12179561 0.79 CTSS (0.55) CTSKCTSSCA1CA2CXCR3
SCHEMBL16520542 0.78 CTSK (0.65) CTSKCTSSSIRT6SIRT1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026866-A1 LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION NEUROPORE THERAPIES, INC. (US) 2018-02-08 WO disclosed